February 1, 2013
The Pharmaceutical Affairs and Food Sanitation Council’s Second Committee on Drugs, an advisory organ of the Minister of Health, Labor and Welfare, recommended approval for GlaxoSmithKline’s Arzerra for I.V. Infusion 100 mg/1,000 mg (ofatumumab) on January 31. The approval for...read more